![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-desktop-w27gif-57924.gif)
![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-mobile-w27gif-62411.gif)
API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
EU WC
0
Listed Suppliers
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.fiercepharma.com/marketing/bms-taps-taye-diggs-its-best-man-schizophrenia-educational-campaign
https://www.biopharmadive.com/news/karuna-schizophrenia-emergent-3-trial-karxt/645392/#:~:text=The%20results%20add%20to%20a,living%20with%20the%20brain%20disorder.&text=An%20experimental%20drug%20from%20Karuna,a%20potential%20therapy%20for%20schizophrenia.
http://www.pharmafile.com/news/722654/karuna-therapeutics-announces-positive-results-phase-iii-trial-schizophrenia
https://ir.zailaboratory.com/news-releases/news-release-details/zai-lab-partner-karuna-therapeutics-announces-positive-results
https://www.biospace.com/article/karuna-therapeutics-launches-ipo-to-raise-89-2-million/
https://www.biospace.com/article/karuna-therapeutics-launches-ipo-to-raise-89-2-million/?s=75
https://endpts.com/quest-for-safe-muscarinic-receptor-agonists-to-tackle-disaster-prone-cns-field-steers-karuna-to-75m-ipo/
https://www.businesswire.com/news/home/20181210005812/en/Karuna-Pharmaceuticals-Present-Results-KarXT-Phase-1
http://www.pmlive.com/pharma_news/daily_brief_karuna_raises_$42m_for_novel_cns_approach,_chen_exits_roche,_orchard_gains_gsk_board_member_1246802